Inventors with similar research interests:
Location History:
- Mission Viego, CA (US) (1991)
- Mission Viejo, CA (US) (1988 - 1994)
- Pompton Lakes, NJ (US) (1993 - 1995)
- Wayne, NJ (US) (1995 - 2004)
- Danville, CA (US) (1999 - 2022)
Company Filing History:
46 out of 126 
21 out of 2,285 
3 out of 10 
Years Active: 1988-2025
Title: Charles Gluchowski: A Pioneer in Neurodegenerative Disease Research
Introduction
Charles Gluchowski, a dedicated inventor based in Danville, California, has made significant contributions to the field of pharmaceutical sciences. With an impressive portfolio of 70 patents, Gluchowski's innovative work focuses primarily on the development of compounds that can inhibit the formation of tau oligomers, which are crucial in the treatment of neurodegenerative diseases.
Latest Patents
Gluchowski's latest patents include groundbreaking inventions such as quinazolinones and benzofuran, benzothiophene, and indole analogs. The patent on quinazolinones that inhibit the formation of tau oligomers outlines novel compounds that are not only effective in treating neurodegenerative diseases but also includes their pharmaceutically acceptable salts, methods for preparation, and potential pharmaceutical compositions.
His work on benzofuran, benzothiophene, and indole analogs further strengthens the arsenal against tau oligomer-related conditions, disclosing similar features as the quinazolinones, ensuring a comprehensive approach to tackling neurodegenerative diseases.
Career Highlights
Throughout his career, Charles Gluchowski has worked with prominent institutions including Synaptic Pharmaceutical Corporation and Allergan, Inc. His experiences in these companies have greatly influenced his research direction and the practical applications of his patents.
Collaborations
Gluchowski has collaborated with accomplished coworkers such as Yoon T Jeon and Wai C Wong, further enriching his research endeavors. These collaborations have led to the advancement of techniques and compounds that support his pioneering work in neurodegenerative disease therapy.
Conclusion
Charles Gluchowski’s relentless dedication to innovation in the pharmaceutical field marks him as a significant contributor to neurodegenerative disease research. His inventions have the potential to transform treatment methodologies, making a lasting impact on the lives of patients suffering from related conditions. Through his extensive patent portfolio and collaborations, Gluchowski continues to push the boundaries of science and innovation.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.